Luis A. Clavell

6.0k total citations
61 papers, 3.9k citations indexed

About

Luis A. Clavell is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Luis A. Clavell has authored 61 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 29 papers in Pediatrics, Perinatology and Child Health and 15 papers in Hematology. Recurrent topics in Luis A. Clavell's work include Acute Lymphoblastic Leukemia research (36 papers), Childhood Cancer Survivors' Quality of Life (28 papers) and Chemotherapy-induced cardiotoxicity and mitigation (13 papers). Luis A. Clavell is often cited by papers focused on Acute Lymphoblastic Leukemia research (36 papers), Childhood Cancer Survivors' Quality of Life (28 papers) and Chemotherapy-induced cardiotoxicity and mitigation (13 papers). Luis A. Clavell collaborates with scholars based in United States, Canada and Puerto Rico. Luis A. Clavell's co-authors include Stephen E. Sallan, Lewis B. Silverman, Marshall A. Schorin, Barbara L. Asselin, Harvey J. Cohen, Donna Neuberg, Steven E. Lipshultz, Richard D. Gelber, Bruno Michon and Uma H. Athale and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Luis A. Clavell

60 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis A. Clavell United States 28 1.8k 1.8k 1.3k 849 782 61 3.9k
Laurel J. Steinherz United States 22 682 0.4× 629 0.4× 1.5k 1.1× 800 0.9× 430 0.5× 37 2.7k
Brigid G. Leventhal United States 35 1.1k 0.6× 608 0.3× 102 0.1× 676 0.8× 632 0.8× 108 3.7k
Arnold I. Freeman United States 37 1.1k 0.6× 542 0.3× 102 0.1× 1.0k 1.2× 846 1.1× 117 4.3k
Colin G. Steward United Kingdom 37 948 0.5× 372 0.2× 215 0.2× 868 1.0× 1.8k 2.2× 111 4.9k
Anne Angiolillo United States 22 807 0.5× 647 0.4× 48 0.0× 915 1.1× 426 0.5× 76 2.7k
Yoshihiro Komada Japan 27 316 0.2× 227 0.1× 297 0.2× 585 0.7× 572 0.7× 191 3.0k
Frederick G. Behm United States 43 3.8k 2.1× 1.7k 0.9× 77 0.1× 1.5k 1.8× 3.7k 4.7× 98 7.6k
Paul L. Martin United States 27 970 0.5× 565 0.3× 77 0.1× 489 0.6× 906 1.2× 74 3.9k
Chiara Messina Italy 37 1.1k 0.6× 841 0.5× 41 0.0× 847 1.0× 2.1k 2.7× 134 3.6k
Lynette D. Fairbanks United Kingdom 31 617 0.3× 438 0.3× 83 0.1× 526 0.6× 231 0.3× 116 3.5k

Countries citing papers authored by Luis A. Clavell

Since Specialization
Citations

This map shows the geographic impact of Luis A. Clavell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis A. Clavell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis A. Clavell more than expected).

Fields of papers citing papers by Luis A. Clavell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis A. Clavell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis A. Clavell. The network helps show where Luis A. Clavell may publish in the future.

Co-authorship network of co-authors of Luis A. Clavell

This figure shows the co-authorship network connecting the top 25 collaborators of Luis A. Clavell. A scholar is included among the top collaborators of Luis A. Clavell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis A. Clavell. Luis A. Clavell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soto‐Salgado, Marievelisse, et al.. (2023). Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012–2016. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1030–1037. 3 indexed citations
2.
Ladas, Elena J., Traci M. Blonquist, Mäneka Puligandla, et al.. (2020). Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort. Journal of Clinical Oncology. 38(19). 2151–2159. 10 indexed citations
3.
Lipshultz, Steven E., Traci M. Blonquist, Tracie L. Miller, et al.. (2018). CARDIOVASCULAR SIGNALING PROTEINS AS PREDICTORS OF DOXORUBICIN-RELATED CARDIAC EFFECTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Journal of the American College of Cardiology. 71(11). A927–A927. 2 indexed citations
4.
5.
Kahn, Justine M., Uma H. Athale, Luis A. Clavell, et al.. (2016). How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic. Journal of Pediatric Health Care. 31(1). e1–e6. 8 indexed citations
6.
Ladas, Elena J., Manuela Orjuela, Kristen E. Stevenson, et al.. (2016). Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study. Nutrition. 32(10). 1103–1109.e1. 33 indexed citations
7.
8.
Lipshultz, Steven E., Tracie L. Miller, Rebecca E. Scully, et al.. (2012). Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes. Journal of Clinical Oncology. 30(10). 1042–1049. 227 indexed citations
9.
Vrooman, Lynda M., Donna Neuberg, Kristen E. Stevenson, et al.. (2011). The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium. European Journal of Cancer. 47(9). 1373–1379. 90 indexed citations
10.
Lipshultz, Steven E., Tracie L. Miller, Rebecca E. Scully, et al.. (2010). Abstract 20432: Diagnostic Value of Cardiac Troponin T, N-Terminal Pro-Brain Natriuretic Peptide, and High-Sensitivity C-Reactive Protein During Doxorubicin Therapy in Children with Acute Lymphoblastic Leukemia. Circulation. 122. 2 indexed citations
11.
Lipshultz, Steven E., Rebecca E. Scully, Stuart R. Lipsitz, et al.. (2010). Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. The Lancet Oncology. 11(10). 950–961. 317 indexed citations
12.
Vrooman, Lynda M., Jeffrey G. Supko, Donna Neuberg, et al.. (2009). Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 54(2). 199–205. 126 indexed citations
13.
Lipshultz, Steven E., Nader Rifai, Virginia Dalton, et al.. (2004). The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia. New England Journal of Medicine. 351(2). 145–153. 422 indexed citations
14.
Clavell, Luis A., et al.. (1998). Giant Platelets with Abnormal Surface Glycoproteins. Journal of Pediatric Hematology/Oncology. 20(1). 69–73. 7 indexed citations
15.
Gelber, Richard D., Stephen E. Sallan, Harvey J. Cohen, et al.. (1993). Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985. Cancer. 72(1). 261–270. 30 indexed citations
16.
Kreissman, Susan G., et al.. (1992). Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia. Cancer. 70(8). 2208–2213. 35 indexed citations
17.
Clavell, Luis A., et al.. (1990). Treatment outcome in children with malignancies associated with human immunodeficiency virus infection. The Journal of Pediatrics. 116(5). 735–738. 20 indexed citations
18.
Larsen, Eric, Antonio R. Pérez‐Atayde, Daniel M. Green, et al.. (1990). Surgery only for the treatment of patients with stage I (Cassady) Wilms' tumor. Cancer. 66(2). 264–266. 29 indexed citations
19.
Grier, Holcombe E., Richard D. Gelber, Luis A. Clavell, et al.. (1990). Intensive Sequential Chemotherapy for Children with Acute Myelogenous Leukemia. Hämatologie und Bluttransfusion. 33. 193–197. 6 indexed citations
20.
Clavell, Luis A. & Michael A. Bratt. (1972). Hemolytic Interaction of Newcastle Disease Virus and Chicken Erythrocytes. II. Determining Factors. Applied Microbiology. 23(3). 461–470. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurel J. Steinherz Breakdown of academic impact, for papers by Brigid G. Leventhal Breakdown of academic impact, for papers by Arnold I. Freeman Breakdown of academic impact, for papers by Colin G. Steward Breakdown of academic impact, for papers by Anne Angiolillo Breakdown of academic impact, for papers by Yoshihiro Komada Breakdown of academic impact, for papers by Frederick G. Behm Breakdown of academic impact, for papers by Paul L. Martin Breakdown of academic impact, for papers by Chiara Messina Breakdown of academic impact, for papers by Lynette D. Fairbanks
Rankless by CCL
2026